1,225 top medical experts on Renal Cell Carcinoma across 49 countries and 37 U.S. states, including 1,182 MDs (Physicians). This is based on an objective analysis of their Scientific Publications, Clinical Trials, Medicare, and NIH Grants.

  1. Renal Cell Carcinoma: A heterogeneous group of sporadic or hereditary carcinoma derived from cells of the kidneys. There are several subtypes including the clear cells, the papillary, the chromophobe, the collecting duct, the spindle cells (sarcomatoid), or mixed cell-type carcinoma.
  2. Clinical guidelines are the recommended starting point to understand initial steps and current protocols in any disease or procedure:
  3. Broader Categories (#Experts): Adenocarcinoma (2,844), Kidney Neoplasms (2,777).
  4. Clinical Trials ClinicalTrials.gov : at least 1,195 including 121 Active, 554 Completed, 203 Recruiting
  5. Synonyms: Renal Cell Adenocarcinoma, Hypernephroid Carcinoma, Grawitz Tumor, Hypernephroma, Renal Carcinoma


  

        

                    


    Computing Expert Listing ...

);